Apatinib for Advanced Non-squamous Head and Neck Cancer
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2016-12-13
- Target Recruit Count
- 30
- Registration Number
- NCT02989259
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, Beijing, China
IORT Versus CCRT for Pancreatic Cancer
- Conditions
- Pancreatic Cancer Stage IV
- Interventions
- Drug: Sequential chemotherapyRadiation: Intraoperative radiotherapy (IORT)Radiation: Three dimensional conformal radiation therapy (3D-CRT)Drug: Concurrent chemotherapy
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2016-12-05
- Target Recruit Count
- 100
- Registration Number
- NCT02981641
- Locations
- 🇨🇳
CancerIHCAMS, Beijing, Beijing, China
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
- First Posted Date
- 2016-10-24
- Last Posted Date
- 2016-10-24
- Target Recruit Count
- 30
- Registration Number
- NCT02943252
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) & Peking Union Medical College (PUMC), Beijing, Beijing, China
Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer
- Conditions
- Lung Neoplasms
- Interventions
- Procedure: Triportal pulmonary resection surgeryProcedure: Uniportal pulmonary resection surgery
- First Posted Date
- 2016-10-14
- Last Posted Date
- 2016-10-14
- Target Recruit Count
- 356
- Registration Number
- NCT02933294
- Locations
- 🇨🇳
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
🇨🇳Chinese PLA General Hospital, Beijing, China
🇨🇳Beijing Chest Hospital, Beijing, China
Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer
- Conditions
- Bladder Cancer
- Interventions
- Procedure: Intensity modulated radiation therapy, Radical cystectomy
- First Posted Date
- 2016-08-10
- Last Posted Date
- 2020-12-17
- Target Recruit Count
- 59
- Registration Number
- NCT02861196
- Locations
- 🇨🇳
Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
IORT Followed by CCRT or SBRT for Locally Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2016-04-12
- Last Posted Date
- 2017-04-11
- Target Recruit Count
- 70
- Registration Number
- NCT02734680
- Locations
- 🇨🇳
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing, China
Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Lung Adenocarcinoma Harboring Wild-type EGFR
- Conditions
- Lung Adenocarcinoma
- Interventions
- First Posted Date
- 2016-02-25
- Last Posted Date
- 2016-02-25
- Target Recruit Count
- 20
- Registration Number
- NCT02691871
Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer
- Conditions
- Colorectal Cancer
- Interventions
- Procedure: Conventional laparoscopic surgeryProcedure: transrectal specimen extraction
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2016-09-02
- Target Recruit Count
- 366
- Registration Number
- NCT02635503
- Locations
- 🇨🇳
Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, Beijing, China
Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2009-12-03
- Last Posted Date
- 2013-08-12
- Target Recruit Count
- 26
- Registration Number
- NCT01024712
- Locations
- 🇨🇳
Cancer Institute Hospital, Chinese Academy of Medical Sciences, Beijing, China